This hypothesis was supported by genetic studies that identified several causative familial AD mutations in the amyloid production pathway, including to APP, presenilin 1 (PS1) and presenilin 2 (PS2) [36,37,38]. This evidence concerns the gene PSEN2 and Alzheimer disease.